chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: PATIENTS MOTHER FALSIFIED PATIENTS DOB TO OBTAIN  VACCINE
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Idiopathic intracranial hypertension, Lumbar puncture abnormal, Magnetic resonance imaging, Optical coherence tomography
Clinical narrative: Approximately 2 weeks after 2nd Moderna vaccine, I started having pulsating tinnitus in my left ear, which was worse at night and upon lying down. Started having headaches off and on which kept getting worse. Went to eye Dr. in June and was diagnosed with papilledema and was sent to neurologist. Had lumbar puncture and opening pressure was high and was diagnosed with iih.  Never had any problems or symptoms of this until after 2nd dose of Moderna. Was put on Acetazolamide and am now on 1500 mg per day and still having issues with tinnitus and headaches. Supposed to see a neuro-opthamologist in Feb. 2022 for follow up of eyes.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Papilloedema, Tinnitus
Clinical narrative: Approximately 2 weeks after 2nd Moderna vaccine, I started having pulsating tinnitus in my left ear, which was worse at night and upon lying down. Started having headaches off and on which kept getting worse. Went to eye Dr. in June and was diagnosed with papilledema and was sent to neurologist. Had lumbar puncture and opening pressure was high and was diagnosed with iih.  Never had any problems or symptoms of this until after 2nd dose of Moderna. Was put on Acetazolamide and am now on 1500 mg per day and still having issues with tinnitus and headaches. Supposed to see a neuro-opthamologist in Feb. 2022 for follow up of eyes.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Back pain, Blood pressure fluctuation, Blood test normal, Chest X-ray normal
Clinical narrative: HEART RACING, FLUCTUATING BLOOD PRESSURE SINCE THE PFIZER VACCINE, SWEATS, LOW BLOOD PRESSURE, LOW HEART RATE, 96% OXYGEN LEVELS, THEN RACING HEART AND THEN EXTREMELY ELEVATED BLOOD PRESSURE, DIZZINESS, CHEST TIGHTENING IN THE HEART AREA, CHEST PAINS IN GENERAL BOTH RIGHT AND LEFT,  MUSCLE ACHES ALL OVER WITH PRIMARY ACHES IN LIMBS, CHEST AND BACK, HEADACHES, AGITATION, LOW-GRADE FEVER, SWEATS AND FEELING HOT AND UNABLE TO COOL CORE TEMP TO STABLE WITHOUT FEELING OVER HEATED, ALL OF THESE SYMPTOMS STARTED BY THE 3RD DAY BEFORE THE 72 HOUR MARK AT 1:00 AM 11/22/2021 AFTER PFIZER VACCINE DATE 11/19/2021 AT 12:30PM. THIS HAS CONTINUED TO WORSEN OVER THE LAST 72 HOURS. LOSING CONSCIOUSNESS AND AWARENESS WHILE FAINTING TODAY AROUND 9AM THIS MORNING 12/2/2021 -  AFTER WAKING 30 MINS TO 1 HOUR PRIOR TO THE FAINTING OCCURRENCE. DECREASED APPETITE COUPLED  WITH INCREASE THIRST IN THE LAST 48 TO 72 HOURS.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Decreased appetite, Dizziness, Electrocardiogram normal
Clinical narrative: HEART RACING, FLUCTUATING BLOOD PRESSURE SINCE THE PFIZER VACCINE, SWEATS, LOW BLOOD PRESSURE, LOW HEART RATE, 96% OXYGEN LEVELS, THEN RACING HEART AND THEN EXTREMELY ELEVATED BLOOD PRESSURE, DIZZINESS, CHEST TIGHTENING IN THE HEART AREA, CHEST PAINS IN GENERAL BOTH RIGHT AND LEFT,  MUSCLE ACHES ALL OVER WITH PRIMARY ACHES IN LIMBS, CHEST AND BACK, HEADACHES, AGITATION, LOW-GRADE FEVER, SWEATS AND FEELING HOT AND UNABLE TO COOL CORE TEMP TO STABLE WITHOUT FEELING OVER HEATED, ALL OF THESE SYMPTOMS STARTED BY THE 3RD DAY BEFORE THE 72 HOUR MARK AT 1:00 AM 11/22/2021 AFTER PFIZER VACCINE DATE 11/19/2021 AT 12:30PM. THIS HAS CONTINUED TO WORSEN OVER THE LAST 72 HOURS. LOSING CONSCIOUSNESS AND AWARENESS WHILE FAINTING TODAY AROUND 9AM THIS MORNING 12/2/2021 -  AFTER WAKING 30 MINS TO 1 HOUR PRIOR TO THE FAINTING OCCURRENCE. DECREASED APPETITE COUPLED  WITH INCREASE THIRST IN THE LAST 48 TO 72 HOURS.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Heart rate decreased, Hyperhidrosis, Hypertension
Clinical narrative: HEART RACING, FLUCTUATING BLOOD PRESSURE SINCE THE PFIZER VACCINE, SWEATS, LOW BLOOD PRESSURE, LOW HEART RATE, 96% OXYGEN LEVELS, THEN RACING HEART AND THEN EXTREMELY ELEVATED BLOOD PRESSURE, DIZZINESS, CHEST TIGHTENING IN THE HEART AREA, CHEST PAINS IN GENERAL BOTH RIGHT AND LEFT,  MUSCLE ACHES ALL OVER WITH PRIMARY ACHES IN LIMBS, CHEST AND BACK, HEADACHES, AGITATION, LOW-GRADE FEVER, SWEATS AND FEELING HOT AND UNABLE TO COOL CORE TEMP TO STABLE WITHOUT FEELING OVER HEATED, ALL OF THESE SYMPTOMS STARTED BY THE 3RD DAY BEFORE THE 72 HOUR MARK AT 1:00 AM 11/22/2021 AFTER PFIZER VACCINE DATE 11/19/2021 AT 12:30PM. THIS HAS CONTINUED TO WORSEN OVER THE LAST 72 HOURS. LOSING CONSCIOUSNESS AND AWARENESS WHILE FAINTING TODAY AROUND 9AM THIS MORNING 12/2/2021 -  AFTER WAKING 30 MINS TO 1 HOUR PRIOR TO THE FAINTING OCCURRENCE. DECREASED APPETITE COUPLED  WITH INCREASE THIRST IN THE LAST 48 TO 72 HOURS.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Myalgia, Pain in extremity, Palpitations, Pyrexia
Clinical narrative: HEART RACING, FLUCTUATING BLOOD PRESSURE SINCE THE PFIZER VACCINE, SWEATS, LOW BLOOD PRESSURE, LOW HEART RATE, 96% OXYGEN LEVELS, THEN RACING HEART AND THEN EXTREMELY ELEVATED BLOOD PRESSURE, DIZZINESS, CHEST TIGHTENING IN THE HEART AREA, CHEST PAINS IN GENERAL BOTH RIGHT AND LEFT,  MUSCLE ACHES ALL OVER WITH PRIMARY ACHES IN LIMBS, CHEST AND BACK, HEADACHES, AGITATION, LOW-GRADE FEVER, SWEATS AND FEELING HOT AND UNABLE TO COOL CORE TEMP TO STABLE WITHOUT FEELING OVER HEATED, ALL OF THESE SYMPTOMS STARTED BY THE 3RD DAY BEFORE THE 72 HOUR MARK AT 1:00 AM 11/22/2021 AFTER PFIZER VACCINE DATE 11/19/2021 AT 12:30PM. THIS HAS CONTINUED TO WORSEN OVER THE LAST 72 HOURS. LOSING CONSCIOUSNESS AND AWARENESS WHILE FAINTING TODAY AROUND 9AM THIS MORNING 12/2/2021 -  AFTER WAKING 30 MINS TO 1 HOUR PRIOR TO THE FAINTING OCCURRENCE. DECREASED APPETITE COUPLED  WITH INCREASE THIRST IN THE LAST 48 TO 72 HOURS.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope, Thirst, Urine analysis normal
Clinical narrative: HEART RACING, FLUCTUATING BLOOD PRESSURE SINCE THE PFIZER VACCINE, SWEATS, LOW BLOOD PRESSURE, LOW HEART RATE, 96% OXYGEN LEVELS, THEN RACING HEART AND THEN EXTREMELY ELEVATED BLOOD PRESSURE, DIZZINESS, CHEST TIGHTENING IN THE HEART AREA, CHEST PAINS IN GENERAL BOTH RIGHT AND LEFT,  MUSCLE ACHES ALL OVER WITH PRIMARY ACHES IN LIMBS, CHEST AND BACK, HEADACHES, AGITATION, LOW-GRADE FEVER, SWEATS AND FEELING HOT AND UNABLE TO COOL CORE TEMP TO STABLE WITHOUT FEELING OVER HEATED, ALL OF THESE SYMPTOMS STARTED BY THE 3RD DAY BEFORE THE 72 HOUR MARK AT 1:00 AM 11/22/2021 AFTER PFIZER VACCINE DATE 11/19/2021 AT 12:30PM. THIS HAS CONTINUED TO WORSEN OVER THE LAST 72 HOURS. LOSING CONSCIOUSNESS AND AWARENESS WHILE FAINTING TODAY AROUND 9AM THIS MORNING 12/2/2021 -  AFTER WAKING 30 MINS TO 1 HOUR PRIOR TO THE FAINTING OCCURRENCE. DECREASED APPETITE COUPLED  WITH INCREASE THIRST IN THE LAST 48 TO 72 HOURS.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling cold, Injection site pain
Clinical narrative: Feeling cold, general strange feeling, more than usual soreness at injection site
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administration error
Clinical narrative: Administrative error.  Administered 0.5ml dose instead of 0.5mg or .25ml.   No adverse symptoms from patient or complaints.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: The first 15 min my right arm was sore and I thought it was normal,  few hours later the pain was a 10, Nausea and headache that it lasted 3 hours, I went to the ER at around 4PM that same day and I was given a morphine shot for the pain.
Age: 17.0
Sex: F
Vaccine: COVID19, FLUR4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Misread age on consent form. I thought 2004 was 2001. Patient not over 18 years of age.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received booster dose early, Date of dose #2 was 07/15/21. Patient was not due for booster until 01/15/2021.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: PT GOT DIZZY, BP UP A LITTLE.PT WAITED AN HOUR THEN WENT HOME. TALKED TO HER LATER SAID HAD WORKED ALL DAY, JUST FELT A LITTLE FUNKY.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Blood chloride decreased, Blood glucose increased, Blood sodium decreased
Clinical narrative: Patient discharged after (3) day inpatient admission.  A patient is a 59 y.o. male with a past medical history significant for diabetes mellitus type 2, essential hypertension, hyperlipidemia, and BPH who presented with a chief complaint of shortness of breath.  The patient reports the symptoms began approximately 7 prior to arrival.  He noted shortness of breath, nonproductive cough, diarrhea (2 days duration).    He was diagnosed with COVID-19 on 11/23/2021.  He was previously vaccinated for COVID-19 with 2 doses of Moderna.     In the ER, he was noted to be tachypneic and hypoxic on room air.  He was subsequently placed on 2 L nasal cannula.  CMP was significant for sodium of 130, chloride 93, glucose 247. Complete blood count demonstrated leukocytosis 12.46, hemoglobin of 12.9 and platelets of 408. Chest x-ray demonstrating moderate bilateral hazy and streaky peripheral non-uniform pulmonary opacities consistent with pneumonitis.  The patient received a dose of Decadron 6 mg IV in the ER.  He was then transferred to hospital for admission as inpatient status in stable condition for further workup, monitoring, and treatment.   Inpatient course:  Patient continued on Decadron.  Remedesivir started on 11/28.  DVT prophylaxis with Lovenox.  His home diabetes medications were held and he was started on basal-bolus insulin per inpatient protocol.  His Lisinopril, Tamsulosin, and Statin were continued.  With steroids, remdesivir and pulmonary toilet patient's respiratory status did improve.  He had improvement in his energy level as well as oral intake.  He was seen by pulmonary rehab on 12/01, and prescribed supplemental oxygen at the time of discharge, with 1 L/Min at rest and 4 L/Min with activity.  As the patient was clinically improved, he was transitioned to oral Decadron which was continued at the time of discharge.  The patient was discharged to home on 12/01/2021.  The patient was encouraged to follow up with his PCP within 7-10 days, for re-evaluation of O2 requirements.  He was instructed that he may not return to his factory work until he has been weaned off of supplemental oxygen.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Patient discharged after (3) day inpatient admission.  A patient is a 59 y.o. male with a past medical history significant for diabetes mellitus type 2, essential hypertension, hyperlipidemia, and BPH who presented with a chief complaint of shortness of breath.  The patient reports the symptoms began approximately 7 prior to arrival.  He noted shortness of breath, nonproductive cough, diarrhea (2 days duration).    He was diagnosed with COVID-19 on 11/23/2021.  He was previously vaccinated for COVID-19 with 2 doses of Moderna.     In the ER, he was noted to be tachypneic and hypoxic on room air.  He was subsequently placed on 2 L nasal cannula.  CMP was significant for sodium of 130, chloride 93, glucose 247. Complete blood count demonstrated leukocytosis 12.46, hemoglobin of 12.9 and platelets of 408. Chest x-ray demonstrating moderate bilateral hazy and streaky peripheral non-uniform pulmonary opacities consistent with pneumonitis.  The patient received a dose of Decadron 6 mg IV in the ER.  He was then transferred to hospital for admission as inpatient status in stable condition for further workup, monitoring, and treatment.   Inpatient course:  Patient continued on Decadron.  Remedesivir started on 11/28.  DVT prophylaxis with Lovenox.  His home diabetes medications were held and he was started on basal-bolus insulin per inpatient protocol.  His Lisinopril, Tamsulosin, and Statin were continued.  With steroids, remdesivir and pulmonary toilet patient's respiratory status did improve.  He had improvement in his energy level as well as oral intake.  He was seen by pulmonary rehab on 12/01, and prescribed supplemental oxygen at the time of discharge, with 1 L/Min at rest and 4 L/Min with activity.  As the patient was clinically improved, he was transitioned to oral Decadron which was continued at the time of discharge.  The patient was discharged to home on 12/01/2021.  The patient was encouraged to follow up with his PCP within 7-10 days, for re-evaluation of O2 requirements.  He was instructed that he may not return to his factory work until he has been weaned off of supplemental oxygen.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count abnormal, Haemoglobin decreased, Hypophagia, Hypoxia, Impaired work ability
Clinical narrative: Patient discharged after (3) day inpatient admission.  A patient is a 59 y.o. male with a past medical history significant for diabetes mellitus type 2, essential hypertension, hyperlipidemia, and BPH who presented with a chief complaint of shortness of breath.  The patient reports the symptoms began approximately 7 prior to arrival.  He noted shortness of breath, nonproductive cough, diarrhea (2 days duration).    He was diagnosed with COVID-19 on 11/23/2021.  He was previously vaccinated for COVID-19 with 2 doses of Moderna.     In the ER, he was noted to be tachypneic and hypoxic on room air.  He was subsequently placed on 2 L nasal cannula.  CMP was significant for sodium of 130, chloride 93, glucose 247. Complete blood count demonstrated leukocytosis 12.46, hemoglobin of 12.9 and platelets of 408. Chest x-ray demonstrating moderate bilateral hazy and streaky peripheral non-uniform pulmonary opacities consistent with pneumonitis.  The patient received a dose of Decadron 6 mg IV in the ER.  He was then transferred to hospital for admission as inpatient status in stable condition for further workup, monitoring, and treatment.   Inpatient course:  Patient continued on Decadron.  Remedesivir started on 11/28.  DVT prophylaxis with Lovenox.  His home diabetes medications were held and he was started on basal-bolus insulin per inpatient protocol.  His Lisinopril, Tamsulosin, and Statin were continued.  With steroids, remdesivir and pulmonary toilet patient's respiratory status did improve.  He had improvement in his energy level as well as oral intake.  He was seen by pulmonary rehab on 12/01, and prescribed supplemental oxygen at the time of discharge, with 1 L/Min at rest and 4 L/Min with activity.  As the patient was clinically improved, he was transitioned to oral Decadron which was continued at the time of discharge.  The patient was discharged to home on 12/01/2021.  The patient was encouraged to follow up with his PCP within 7-10 days, for re-evaluation of O2 requirements.  He was instructed that he may not return to his factory work until he has been weaned off of supplemental oxygen.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Leukocytosis, Lung opacity, Metabolic function test, Platelet count increased, Pneumonitis
Clinical narrative: Patient discharged after (3) day inpatient admission.  A patient is a 59 y.o. male with a past medical history significant for diabetes mellitus type 2, essential hypertension, hyperlipidemia, and BPH who presented with a chief complaint of shortness of breath.  The patient reports the symptoms began approximately 7 prior to arrival.  He noted shortness of breath, nonproductive cough, diarrhea (2 days duration).    He was diagnosed with COVID-19 on 11/23/2021.  He was previously vaccinated for COVID-19 with 2 doses of Moderna.     In the ER, he was noted to be tachypneic and hypoxic on room air.  He was subsequently placed on 2 L nasal cannula.  CMP was significant for sodium of 130, chloride 93, glucose 247. Complete blood count demonstrated leukocytosis 12.46, hemoglobin of 12.9 and platelets of 408. Chest x-ray demonstrating moderate bilateral hazy and streaky peripheral non-uniform pulmonary opacities consistent with pneumonitis.  The patient received a dose of Decadron 6 mg IV in the ER.  He was then transferred to hospital for admission as inpatient status in stable condition for further workup, monitoring, and treatment.   Inpatient course:  Patient continued on Decadron.  Remedesivir started on 11/28.  DVT prophylaxis with Lovenox.  His home diabetes medications were held and he was started on basal-bolus insulin per inpatient protocol.  His Lisinopril, Tamsulosin, and Statin were continued.  With steroids, remdesivir and pulmonary toilet patient's respiratory status did improve.  He had improvement in his energy level as well as oral intake.  He was seen by pulmonary rehab on 12/01, and prescribed supplemental oxygen at the time of discharge, with 1 L/Min at rest and 4 L/Min with activity.  As the patient was clinically improved, he was transitioned to oral Decadron which was continued at the time of discharge.  The patient was discharged to home on 12/01/2021.  The patient was encouraged to follow up with his PCP within 7-10 days, for re-evaluation of O2 requirements.  He was instructed that he may not return to his factory work until he has been weaned off of supplemental oxygen.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea, White blood cell count increased
Clinical narrative: Patient discharged after (3) day inpatient admission.  A patient is a 59 y.o. male with a past medical history significant for diabetes mellitus type 2, essential hypertension, hyperlipidemia, and BPH who presented with a chief complaint of shortness of breath.  The patient reports the symptoms began approximately 7 prior to arrival.  He noted shortness of breath, nonproductive cough, diarrhea (2 days duration).    He was diagnosed with COVID-19 on 11/23/2021.  He was previously vaccinated for COVID-19 with 2 doses of Moderna.     In the ER, he was noted to be tachypneic and hypoxic on room air.  He was subsequently placed on 2 L nasal cannula.  CMP was significant for sodium of 130, chloride 93, glucose 247. Complete blood count demonstrated leukocytosis 12.46, hemoglobin of 12.9 and platelets of 408. Chest x-ray demonstrating moderate bilateral hazy and streaky peripheral non-uniform pulmonary opacities consistent with pneumonitis.  The patient received a dose of Decadron 6 mg IV in the ER.  He was then transferred to hospital for admission as inpatient status in stable condition for further workup, monitoring, and treatment.   Inpatient course:  Patient continued on Decadron.  Remedesivir started on 11/28.  DVT prophylaxis with Lovenox.  His home diabetes medications were held and he was started on basal-bolus insulin per inpatient protocol.  His Lisinopril, Tamsulosin, and Statin were continued.  With steroids, remdesivir and pulmonary toilet patient's respiratory status did improve.  He had improvement in his energy level as well as oral intake.  He was seen by pulmonary rehab on 12/01, and prescribed supplemental oxygen at the time of discharge, with 1 L/Min at rest and 4 L/Min with activity.  As the patient was clinically improved, he was transitioned to oral Decadron which was continued at the time of discharge.  The patient was discharged to home on 12/01/2021.  The patient was encouraged to follow up with his PCP within 7-10 days, for re-evaluation of O2 requirements.  He was instructed that he may not return to his factory work until he has been weaned off of supplemental oxygen.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration error: Dose administered 18 days after the expiry date.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Electrocardiogram normal, Pain in extremity, Paraesthesia
Clinical narrative: When I got home I felt a sharp pain in my right shoulder. Also, that night my right side arm was tingling and felt like needles. Later in the week I had a sudden pain in my chest. By Wednesday I had called the doctor for advice. On that Thursday saw the doctor and had EKG and it came back normal. Take Tylenol and drink plenty.  Pain and tingling subsided but still feel it in both hands fingers.
Age: 26.0
Sex: F
Vaccine: FLUN4
Symptoms: Fatigue, Frustration tolerance decreased, Impaired work ability, Malaise, Oropharyngeal pain
Clinical narrative: I got the vaccine Monday evening and Wednesday evening (2 days later) I was feeling unwell. I started having a runny nose and congestion as well as a sore throat. I felt fatigued as well. The next day on Thursday I felt even worse and could not sleep half the night (Wednesday night) so I felt awful trying to go to work. I was required to get 2 Covid tests for work which were both negative, then they let me work. I am a healthcare professional, and it was frustrating having to be tested 2 times for Covid when I knew it was just a reaction from the FluMist.
Age: 26.0
Sex: F
Vaccine: FLUN4
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative, Sleep disorder
Clinical narrative: I got the vaccine Monday evening and Wednesday evening (2 days later) I was feeling unwell. I started having a runny nose and congestion as well as a sore throat. I felt fatigued as well. The next day on Thursday I felt even worse and could not sleep half the night (Wednesday night) so I felt awful trying to go to work. I was required to get 2 Covid tests for work which were both negative, then they let me work. I am a healthcare professional, and it was frustrating having to be tested 2 times for Covid when I knew it was just a reaction from the FluMist.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient developed itchiness under the left arm on ribs, gave 10ml oral benadryl and symptoms were beginning to resolve after approximately 30 minutes.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 9.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Pink raised area at injection site 2 inches by 1 inch lasting 8 days.
Age: 9.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pink raised area at injection site 2 inches by 1 inch lasting 8 days.
Age: 9.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: one day after injection in left arm patient developed bright red area over site (approx 1.5x 2inches) that was warm and tender to touch.   this persisted for 8 days and then began to fade in color and was less tender to touch.  patient could use his arm normally with full ROM and had normal muscle strength.
Age: 9.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: one day after injection in left arm patient developed bright red area over site (approx 1.5x 2inches) that was warm and tender to touch.   this persisted for 8 days and then began to fade in color and was less tender to touch.  patient could use his arm normally with full ROM and had normal muscle strength.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Feeling abnormal, Feeling hot
Clinical narrative: Fatigue lasting at least one week, fever, chills, extreme hot, lack of sleep, sweating, increased heart rate, brain fog, headache last at least a week, decreased lung capacity, shallow breathing, wheezing with activity (where there was none before), out of breath doing mundane tasks (where there was no issue before), lasting tiredness.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Hyperhidrosis, Hypopnoea, Insomnia
Clinical narrative: Fatigue lasting at least one week, fever, chills, extreme hot, lack of sleep, sweating, increased heart rate, brain fog, headache last at least a week, decreased lung capacity, shallow breathing, wheezing with activity (where there was none before), out of breath doing mundane tasks (where there was no issue before), lasting tiredness.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Total lung capacity decreased, Wheezing
Clinical narrative: Fatigue lasting at least one week, fever, chills, extreme hot, lack of sleep, sweating, increased heart rate, brain fog, headache last at least a week, decreased lung capacity, shallow breathing, wheezing with activity (where there was none before), out of breath doing mundane tasks (where there was no issue before), lasting tiredness.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: Administration error: Dose administered 6 days after the expiry date.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Extra dose administered, Fatigue, Headache
Clinical narrative: Sore arm at injection site within 4 hours of booster.  fatigue, nausea, body aches/pains, chills, slight headache started about 7 hours after booster. Mostly improved next morning, however light headed and mild aches. Rested dec 2. Eve of Dec 2 aches returning, slight nausea. Still experiencing. Taking ibuprofen and resting
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Nausea, Pain
Clinical narrative: Sore arm at injection site within 4 hours of booster.  fatigue, nausea, body aches/pains, chills, slight headache started about 7 hours after booster. Mostly improved next morning, however light headed and mild aches. Rested dec 2. Eve of Dec 2 aches returning, slight nausea. Still experiencing. Taking ibuprofen and resting
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, C-reactive protein increased, Erythema nodosum, Full blood count normal, HIV test negative
Clinical narrative: Erythema nodosum developed 1 week after vaccination, improving with time.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Human chorionic gonadotropin negative, Red blood cell sedimentation rate normal, Streptococcus test negative
Clinical narrative: Erythema nodosum developed 1 week after vaccination, improving with time.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received 4th full dose of vaccine, patient was immunocompromised.  Patient forgot that she had a third full at another pharmacy a few months ago.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Covid +  SOB
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: None. Administration Error dose administered 6 days after the QR code expiry date.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: The patient presented to our mobile vaccine clinic,  without her vaccination card, with her parent, requesting a "booster" for her. The patient's prior vaccination status was not verified and the patient received a third dose of Pfizer vaccine. Dates of vaccine for this patient  are as follows:  5/14/21,  6/3/21 and 12/1/21. The following morning (approx 14 hours later) the patient was  given ibuprofen by her father for fever. About 7 hours after the ibuprofen, she had fever to 101 degrees, some myalgia, fatigue, nausea and vomiting. She was reportedly given acetaminophen, and was advised to take oral rehydration and parents to continue monitoring. There was NO report of confusion, seizure, altered mental status, chest pain, rash, hives nor shortness of breath. ER warnings were given and the patient's father was referred to a local pediatric infectious disease specialist for an appointment for the patient.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: The patient presented to our mobile vaccine clinic,  without her vaccination card, with her parent, requesting a "booster" for her. The patient's prior vaccination status was not verified and the patient received a third dose of Pfizer vaccine. Dates of vaccine for this patient  are as follows:  5/14/21,  6/3/21 and 12/1/21. The following morning (approx 14 hours later) the patient was  given ibuprofen by her father for fever. About 7 hours after the ibuprofen, she had fever to 101 degrees, some myalgia, fatigue, nausea and vomiting. She was reportedly given acetaminophen, and was advised to take oral rehydration and parents to continue monitoring. There was NO report of confusion, seizure, altered mental status, chest pain, rash, hives nor shortness of breath. ER warnings were given and the patient's father was referred to a local pediatric infectious disease specialist for an appointment for the patient.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Heavy menstrual bleeding, Polymenorrhoea
Clinical narrative: A few days after the booster I got my period for 8 days. I just had my period 2 weeks earlier. My period is always on schedule. Every 30 days 5 to 7 days. Now I have no idea. It was a very scary heavy period I thought something was wrong.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Patient was scheduled for a flu shot and was incorrectly given a Covid shot instead.  He had already gotten his booster dose.    He reported no adverse events from the incorrect vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Impaired work ability, Inflammation, Loss of personal independence in daily activities, Malaise
Clinical narrative: Extreme fatigue for over a month, had to work from bed for a month, barely left home, parents had to bring food over, increased inflammation, extreme malaise, over a month later and I am just able to work from my desk again
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abnormal, Echocardiogram, Facial paralysis, Head discomfort, Magnetic resonance imaging abnormal
Clinical narrative: I had a TIA that lasted about 10 minutes on April 30, 2021, (approx. 3 weeks after the second vaccine).   The back of my head felt 'funny' , not dizzy, but like things getting farther away.  I could talk and raise my arms up, but when I tried to smile, the right side of my mouth drooped, thus I thought I was having a stroke. My partner drove me to the hospital where I was given an MRI, CAT scan in the next hour or so.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroid mass, Transient ischaemic attack, Ultrasound Doppler, Ultrasound thyroid abnormal
Clinical narrative: I had a TIA that lasted about 10 minutes on April 30, 2021, (approx. 3 weeks after the second vaccine).   The back of my head felt 'funny' , not dizzy, but like things getting farther away.  I could talk and raise my arms up, but when I tried to smile, the right side of my mouth drooped, thus I thought I was having a stroke. My partner drove me to the hospital where I was given an MRI, CAT scan in the next hour or so.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pruritus, Rash
Clinical narrative: ittle itchy on my ankles; rash; received the second dose more than a month after the first one; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (ittle itchy on my ankles), RASH (rash) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose more than a month after the first one) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033L21A and 050E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced PRURITUS (ittle itchy on my ankles), RASH (rash) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose more than a month after the first one). The patient was treated with CORTISONE ACETATE (CORTISONE [CORTISONE ACETATE]) for Adverse event, at an unspecified dose and frequency. In November 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose more than a month after the first one) had resolved. At the time of the report, PRURITUS (ittle itchy on my ankles) and RASH (rash) outcome was unknown.            No concomitant products were reported. The patient reported that never had something like this. Treatment medication Niesporm was put on a Monday and did not do any good.   Most recent FOLLOW-UP information incorporated above includes: On 24-Nov-2021: Source Document contains no new information
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Illness, Nausea
Clinical narrative: diarrhea; Really sick; headache; nausea; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Nov-2021 and was forwarded to Moderna on 24-Nov-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ILLNESS (Really sick), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, the patient experienced DIARRHOEA (diarrhea), ILLNESS (Really sick), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), ILLNESS (Really sick), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.            No Concomitant medication details were provided. No Treatment medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Nov-2021: Follow up received on 24-Nov-2021 contains no new information.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Feeling abnormal, Headache, Injection site pain
Clinical narrative: Achey stiff upper body, sore at site of injection, loss of appetite, headache, feeling ?out of it?, fatigue
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Achey stiff upper body, sore at site of injection, loss of appetite, headache, feeling ?out of it?, fatigue
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood chloride decreased, Blood sodium decreased, COVID-19, Chest X-ray normal, Lymphocyte count normal
Clinical narrative: Patient was seen for routine lab work as an outpatient on 12/2. The patient was found to have a low serum sodium and sent to ED for evaluation. Patient is a daily alcohol drinker. The patient was tested for COVID-19 and found to be positive. The patient is being admitted to the hospital.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count decreased, SARS-CoV-2 test positive, White blood cell count decreased
Clinical narrative: Patient was seen for routine lab work as an outpatient on 12/2. The patient was found to have a low serum sodium and sent to ED for evaluation. Patient is a daily alcohol drinker. The patient was tested for COVID-19 and found to be positive. The patient is being admitted to the hospital.
Age: 10.0
Sex: F
Vaccine: FLUC4
Symptoms: Extra dose administered
Clinical narrative: Parent brought child to a vaccine event and requested an influenza vaccination be given.  No access to system and it was identified when the record was recorded a few days later, the patient had already received the influenza vaccination.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 13 days after the QR code expiry date
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Feeling hot, Headache
Clinical narrative: Chills, nauseous, hot, feeling hot, lack of sleep, extreme fatigue, persisting lack of energy and performance, headache, arm pain, shallow breathing, less lung capacity, wheezing during exercise, heavy breathing during mundane tasks.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Hypopnoea, Insomnia, Nausea, Pain in extremity, Performance status decreased
Clinical narrative: Chills, nauseous, hot, feeling hot, lack of sleep, extreme fatigue, persisting lack of energy and performance, headache, arm pain, shallow breathing, less lung capacity, wheezing during exercise, heavy breathing during mundane tasks.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Skin warm, Total lung capacity decreased, Wheezing
Clinical narrative: Chills, nauseous, hot, feeling hot, lack of sleep, extreme fatigue, persisting lack of energy and performance, headache, arm pain, shallow breathing, less lung capacity, wheezing during exercise, heavy breathing during mundane tasks.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting all day
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 16 days after the QR code expiry date
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: none
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 13 days after the QR code expiry date
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 6.0
Sex: F
Vaccine: FLUA4
Symptoms: Extra dose administered
Clinical narrative: Parent brought child to a vaccination clinic and requested an influenza vaccination.  No access to system, but when entered a few days later it was discovered the child had received a vaccine two days previously at a local pharmacy.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Dizziness, Dyspnoea, Electrocardiogram abnormal, Fatigue
Clinical narrative: Fever 103, exhaustion, aches, respiratory symptoms, increased shortness of breath, nausea, lightheaded like going to pass out
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Respiratory symptom, Sinus rhythm
Clinical narrative: Fever 103, exhaustion, aches, respiratory symptoms, increased shortness of breath, nausea, lightheaded like going to pass out
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid +
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Pericarditis
Clinical narrative: Patient developed mild pericarditis
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Severe chills, fever, headache
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 13 days after QR code expiry date
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Oral blood blister, Oral mucosal blistering, Petechiae, Platelet transfusion
Clinical narrative: The week he was due to get the second shot he had Petechiae on his stomach, legs and neck. He then presented large (nickel size) blood blister (about 10) inside his mouth. Whenever he popped them they would immediately fill back up. The night before his second shot he was urinating blood (urine was the color of cranberry juice). We went to the ER and they said he has 2 platelets. He had to get multiple platelet transfusions and was admitted for a few days. From there he needed to stay on prednisone for a month or more and see a hematologist weekly.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Loss of consciousness, Pallor, Syncope, Tremor
Clinical narrative: Patient fainted and fell over. Regained consciousness in ~30 seconds from falling. Emergency services was called, fire rescue happen to be shopping to arrived in about 5 minutes. When fire rescue was tending to the patient (maybe about 20 minutes after initial fall) the patient started to shake blacked out for a few seconds again. Patient was pale, but responsive. Fire rescue proceeded to take him away.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Headache
Clinical narrative: A 52-year-old female patient was in the observation area waiting for her 30 minutes and begins to touch her right temporal area and the partner asks her if she feels well, which indicates that she feels a headache. The Head Nurse on duty, was notified and the patient was taken to the observation area, which was evaluated by EMT. Patient presents headache that starts from the right eye to the right temporal area. His vital signs were: B/P 140/90 mmHg, Sat. 99%, Pulse 73, Dxt 124 and presents clear breaths of 16x min on auscultation. Case was consulted with Doctor and 160mg of acetaminophen was administered. At 6:45pm, the patient was reevaluated and her vital signs were: 98% Sat., 67 for strong and regular pulse, 16 breaths, 95 Dxt, and 130/80 mmHg. Then, the patient reports pain in the upper part of the chest and does not report any other symptoms. At 7:19pm, he reports a headache and decreasing chest pressure. The patient voluntarily did not wish to go to the hospital.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 12 days after the QR code expiry date
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Inflammatory marker test, Myalgia, Pain, Pain in extremity
Clinical narrative: Muscles EVERYWHERE ache. Back, limbs neck etc.  Totally incapacitated  me . Burn sensation on patches of my skin in several areas.  Headache that would not go away. Shooting pains in the toes.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Skin burning sensation
Clinical narrative: Muscles EVERYWHERE ache. Back, limbs neck etc.  Totally incapacitated  me . Burn sensation on patches of my skin in several areas.  Headache that would not go away. Shooting pains in the toes.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: pt started to feel dizzy after shot, bp 120/71 and 55 pulse
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Erythema, Eye oedema, Fatigue, Tenderness
Clinical narrative: Patient woke up with discomfort at 4am and around 6 am mom noticed edema and erythema around the eyes, some arm tenderness and fatigue
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Chondritis
Clinical narrative: per pt:  hospitalized a few days after flu vaccine with severe chondritis in the neck, left arm, all lymph nodes on left side,  hositilization lasted 3 days.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None Administration Error- dose administered 6 days after QR code expiry date
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: None Administration Error ? dose administered 6 days after the QR code expiry date
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site pain, Injection site swelling, Syringe issue, Underdose
Clinical narrative: When vaccine was being administered to the patient there was a malfunction in the retractable syringe.   The vaccine liquid was ejected out of the plunger side of the syringe almost like it exploded after the needle was put into the patient's arm.  Because of the malfunction, it is estimated that less than half of the vaccine dose got into the patient's arm.  Immediately  after this happened the patients arm  began to swell at the injection site.  It looked like a hard ball under the skin and the patient felt pain at the injection site. Patient stated that she would drive herself to the urgent care clinic as she believed the needle may have broken off in her arm.